PURPOSE: To develop a protocol which optimizes contrast, resolution and scan time for three-dimensional (3D) imaging of the human eye in vivo using a 7 Tesla (T) scanner and custom radio frequency (RF) coil. MATERIALS AND METHODS: Initial testing was conducted to reduce motion and susceptibility artifacts. Three-dimensional FFE and IR-TFE images were obtained with variable flip angles and TI times. T(1) measurements were made and numerical simulations were performed to determine the ideal contrast of certain ocular structures. Studies were performed to optimize resolution and signal-to-noise ratio (SNR) with scan times from 20 s to 5 min. RESULTS: Motion and susceptibility artifacts were reduced through careful subject preparation. T(1) values of the ocular structures are in line with previous work at 1.5T. A voxel size of 0.15 x 0.25 x 1.0 mm(3) was obtained with a scan time of approximately 35 s for both 3D FFE and IR-TFE sequences. Multiple images were registered in 3D to produce final SNRs over 40. CONCLUSION: Optimization of pulse sequences and avoidance of susceptibility and motion artifacts led to high quality images with spatial resolution and SNR exceeding prior work. Ocular imaging at 7T with a dedicated coil improves the ability to make measurements of the fine structures of the eye.
PURPOSE: To develop a protocol which optimizes contrast, resolution and scan time for three-dimensional (3D) imaging of the human eye in vivo using a 7 Tesla (T) scanner and custom radio frequency (RF) coil. MATERIALS AND METHODS: Initial testing was conducted to reduce motion and susceptibility artifacts. Three-dimensional FFE and IR-TFE images were obtained with variable flip angles and TI times. T(1) measurements were made and numerical simulations were performed to determine the ideal contrast of certain ocular structures. Studies were performed to optimize resolution and signal-to-noise ratio (SNR) with scan times from 20 s to 5 min. RESULTS: Motion and susceptibility artifacts were reduced through careful subject preparation. T(1) values of the ocular structures are in line with previous work at 1.5T. A voxel size of 0.15 x 0.25 x 1.0 mm(3) was obtained with a scan time of approximately 35 s for both 3D FFE and IR-TFE sequences. Multiple images were registered in 3D to produce final SNRs over 40. CONCLUSION: Optimization of pulse sequences and avoidance of susceptibility and motion artifacts led to high quality images with spatial resolution and SNR exceeding prior work. Ocular imaging at 7T with a dedicated coil improves the ability to make measurements of the fine structures of the eye.
Authors: David A Atchison; Emma L Markwell; Sanjeev Kasthurirangan; James M Pope; George Smith; Peter G Swann Journal: J Vis Date: 2008-04-28 Impact factor: 2.240
Authors: William D Rooney; Glyn Johnson; Xin Li; Eric R Cohen; Seong-Gi Kim; Kamil Ugurbil; Charles S Springer Journal: Magn Reson Med Date: 2007-02 Impact factor: 4.668
Authors: Robert J Bert; Shelton D Caruthers; Hernan Jara; Jaroslaw Krejza; Elias R Melhem; Nancy H Kolodny; Samuel Patz; Thomas F Freddo Journal: Invest Ophthalmol Vis Sci Date: 2006-12 Impact factor: 4.799
Authors: Kathryn E Hammond; Janine M Lupo; Duan Xu; Meredith Metcalf; Douglas A C Kelley; Daniel Pelletier; Susan M Chang; Pratik Mukherjee; Daniel B Vigneron; Sarah J Nelson Journal: Neuroimage Date: 2007-11-07 Impact factor: 6.556
Authors: Yi Zhang; Oscar San Emeterio Nateras; Qi Peng; Roman V Kuranov; Joseph M Harrison; Thomas E Milner; Timothy Q Duong Journal: Invest Ophthalmol Vis Sci Date: 2011-09-14 Impact factor: 4.799
Authors: John B Christoforidis; Peter A Wassenaar; Greg A Christoforidis; Vincent Y Ho; Michael V Knopp; Petra M Schmalbrock Journal: Graefes Arch Clin Exp Ophthalmol Date: 2012-09-16 Impact factor: 3.117
Authors: Kathryn Richdale; Loraine T Sinnott; Mark A Bullimore; Peter A Wassenaar; Petra Schmalbrock; Chiu-Yen Kao; Samuel Patz; Donald O Mutti; Adrian Glasser; Karla Zadnik Journal: Invest Ophthalmol Vis Sci Date: 2013-02-07 Impact factor: 4.799
Authors: Leon C Ho; Ian A Sigal; Ning-Jiun Jan; Alexander Squires; Zion Tse; Ed X Wu; Seong-Gi Kim; Joel S Schuman; Kevin C Chan Journal: Invest Ophthalmol Vis Sci Date: 2014-08-07 Impact factor: 4.799